DarioHealth Corp. (DRIO )

Currency in USD Disclaimer
$13.29 +$1.56 (13.3%)
Open 11/17/2025
$10.88
$13.31
$5.94
$31

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol DRIO
  • Company DarioHealth Corp.
  • Price $13.29
  • Changes Percentage 13.3
  • Change 1.56
  • Day Low $10.88
  • Day High $13.31
  • Year High $31
  • Year Low $5.94
  • Market Cap $604,655,130
  • Price Avg 50 EMA (D) $12.61
  • Price Avg 200 EMA (D) $12.92
  • Exchange NASDAQ
  • Volume 103,574
  • Average Volume 68,897
  • Open $11.61
  • Previous Close $11.73
  • EPS -13.4
  • PE -0.99
  • Earnings Announcement 2025-11-13 13:30:00
  • Shares Outstanding $45,497,000

Company brief: DARIOHEALTH CORP. (DRIO )

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DRIO Corporation News

Income Statement